Abstract:Background Recent genome-wide association studies (GWASs) have revealed the polygenic nature of psychiatric disorders and discovered a few of single-nucleotide polymorphisms (SNPs) associated with multiple psychiatric disorders. However, the extent and pattern of pleiotropy among distinct psychiatric disorders remain not completely clear. Methods We analyzed 14 psychiatric disorders using summary statistics available from the largest GWASs by far. We first applied the cross-trait linkage disequilibrium score regression (LDSC) to estimate genetic correlation between disorders. Then, we performed a gene-based pleiotropy analysis by first aggregating a set of SNP-level associations into a single gene-level association signal using MAGMA. From a methodological perspective, we viewed the identification of pleiotropic associations across the entire genome as a high-dimensional problem of composite null hypothesis testing and utilized a novel method called PLACO for pleiotropy mapping. We ultimately implemented functional analysis for identified pleiotropic genes and used Mendelian randomization for detecting causal association between these disorders. Results We confirmed extensive genetic correlation among psychiatric disorders, based on which these disorders can be grouped into three diverse categories. We detected a large number of pleiotropic genes including 5884 associations and 2424 unique genes and found that differentially expressed pleiotropic genes were significantly enriched in pancreas, liver, heart, and brain, and that the biological process of these genes was remarkably enriched in regulating neurodevelopment, neurogenesis, and neuron differentiation, offering substantial evidence supporting the validity of identified pleiotropic loci. We further demonstrated that among all the identified pleiotropic genes there were 342 unique ones linked with 6353 drugs with drug-gene interaction which can be classified into distinct types including inhibitor, agonist, blocker, antagonist, and modulator. We also revealed causal associations among psychiatric disorders, indicating that genetic overlap and causality commonly drove the observed co-existence of these disorders. Conclusions Our study is among the first large-scale effort to characterize gene-level pleiotropy among a greatly expanded set of psychiatric disorders and provides important insight into shared genetic etiology underlying these disorders. The findings would inform psychiatric nosology, identify potential neurobiological mechanisms predisposing to specific clinical presentations, and pave the way to effective drug targets for clinical treatment.

TWAS pathway method greatly enhances the number of leads for uncovering the molecular underpinnings of psychiatric disorders

Improving the detection of pathways in genome-wide association studies by combined effects of SNPs from Linkage Disequilibrium blocks

DeepWAS: Directly Integrating Regulatory Information into GWAS Using Deep Learning Supports Master Regulator MEF2C As Risk Factor for Major Depressive Disorder

Bioinformatics in Psychiatric Genetics

DeepWAS: Multivariate Genotype-Phenotype Associations by Directly Integrating Regulatory Information Using Deep Learning

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders

A novel multi-omics mendelian randomization method for gene set enrichment and its application to psychiatric disorders

A Comprehensive Gene-Centric Pleiotropic Association Analysis for 14 Psychiatric Disorders with GWAS Summary Statistics

DeepGWAS: Enhance GWAS Signals for Neuropsychiatric Disorders Via Deep Neural Network

Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.

Integration of Enhancer-Promoter Interactions with GWAS Summary Results Identifies Novel Schizophrenia-Associated Genes and Pathways

Bayesian Genome-wide TWAS method to leverage both cis- and trans- eQTL information through summary statistics

Single-nucleus transcriptome-wide association study of human brain disorders

A comprehensive framework for trans-ancestry pathway analysis using GWAS summary data from diverse populations

Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes

Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and Compounds

Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder

Using three-dimensional regulatory chromatin interactions from adult and fetal cortex to interpret genetic results for psychiatric disorders and cognitive traits

Multitrait transcriptome‐wide association study (TWAS) tests

Gene and Pathway-Based Second-Wave Analysis of Genome-Wide Association Studies